Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT00814073
Title A Phase 3 Study to Compare Efficacy and Safety of Masitinib to Placebo in the Treatment of Patients With Smouldering Systemic, Indolent Systemic or Cutaneous Mastocytosis With Handicap
Acronym AB06006
Recruitment Completed
Gender both
Phase Phase III
Variant Requirements No
Sponsors AB Science
Indications
Therapies
Age Groups: adult
Covered Countries USA | FRA

Facility Status City State Zip Country Details
UC Davis Health System , Department of Dermatology Sacramento California 95816 United States Details
MD Anderson Cancer Centre Houston Texas 77030 United States Details
CHU d'Amiens Amiens France Details
Hôpital Avicenne Bobigny France Details
CHU de Brest Brest France Details
CHU de Caen Caen France Details
CHU Clermont Ferrand Clermont Ferrand 63000 France Details
Hôpital Claude Huriez Lille France Details
CHU Dupuytren Limoges France Details
Hôpital Ambroise Paré Marseille France Details
Hôpital Nord Marseille France Details
Hôpital Central Nancy France Details
CHU Hôtel Dieu Nantes France Details
Hôpital l'Archet II Nice France Details
Hôpital Necker Paris France Details
Hôpital Tenon Paris France Details
CHU Lyon Sud Pierre Bénite 69495 France Details
Centre Hospitalier Lyon Sud Pierre-Bénite France Details
CHU Milétrie Poitiers France Details
CHU Hôpital Sud Rennes France Details
CHU de Saint-Etienne Saint-Etienne France Details
Hôpital Purpan Toulouse France Details
Hôpital Bretonneau Tours France Details
Hôpital des Hauts Clos Troyes France Details
*Shaded cells indicate that there was no data available from clincialtrials.gov for the field